Research
Metabolic adaptation
Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for diastolic dysfunction and heart failure with preserved ejection fraction (HFpEF), increasing the risk of hospitalization and death in those with established heart failure.
Clinicians should consider screening for MASLD in patients with HFpEF due to the increased risk of adverse outcomes.
StrongSupportsmedium confidence
MASLD is an independent risk factor for diastolic dysfunction and HFpEF, increasing the risk of hospitalization and death in those with established heart failure.
Why this rating
The abstract discusses established relationships and implications based on clinical observations.
Source
Metabolic Dysfunction-Associated Steatotic Liver Disease and Heart Failure with Preserved Ejection Fraction: A Bidirectional Relationship with Clinical and Therapeutic Implications
Ana Rita Leite et al. · Endocrinology Insights · 2024
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →